Home > Boards > US Listed > Miscellaneous > TherapeuticsMD, Inc. (TXMD)

I would not rely on seeking Alpha for

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JCB5 Member Profile
 
Followed By 46
Posts 5,448
Boards Moderated 0
Alias Born 04/16/08
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 2:30:38 PM
TherapeuticsMD to Host Investor and Analyst Day Today Business Wire - 6/10/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 7:16:23 AM
TherapeuticsMD & Theramex Enter into Exclusive License & Supply Agreement to Commercialize BIJUVA™ & IMVEXXY® Outside the ... Business Wire - 6/7/2019 7:15:00 AM
TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City Business Wire - 5/29/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/15/2019 5:29:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2019 7:03:21 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2019 6:01:29 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 5:06:06 PM
TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference Business Wire - 5/8/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2019 4:09:18 PM
TherapeuticsMD Announces First Quarter 2019 Financial Results Business Wire - 5/6/2019 4:05:00 PM
TherapeuticsMD Presented New Research at the American College of Obstetricians & Gynecologists 2019 Annual Meeting that Explo... Business Wire - 5/6/2019 7:00:00 AM
TherapeuticsMD Announces Oral & Poster Presentations on BIJUVA™ & ANNOVERA™ at the American College of Obstetricians & Gy... Business Wire - 5/3/2019 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2019 6:21:37 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/30/2019 6:04:21 AM
TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019 Business Wire - 4/29/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/25/2019 4:36:00 PM
TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners Business Wire - 4/24/2019 4:10:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/17/2019 4:09:52 PM
TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Stre... Business Wire - 4/17/2019 7:05:00 AM
TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S. Business Wire - 4/17/2019 7:00:00 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 4/10/2019 11:10:04 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/8/2019 7:02:02 AM
TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the Endocrine Society 2019 Annual Meet... Business Wire - 3/25/2019 7:00:00 AM
JCB5   Tuesday, 11/07/17 03:56:14 PM
Re: Inoviorulez post# 373
Post # of 407 
I would not rely on seeking Alpha for dd research. They have been pumping this for about two years. Txmd has NEVER made a profit and LOSES 20 million a quarter. Glta.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist